Introduction
============

Exposure to sulfur mustard (SM) leads to short- and long-term adverse effects in various organs including the skin. Skin is the first and most heavily damaged organ upon SM exposure. In Sardasht-Iran Cohort study (SICS), the most common skin symptom was pruritus and the difference between the exposed and control groups was statistically significant ([@B1]). The prevalence of itching in the studies by Moin et al. ([@B1]), Fekri and Janghorbani ([@B2]), Toosi et al. ([@B3]), Hefazi et al. ([@B4]), and Heidari et al., ([@B5]) was 94.7%, 54.8%, 75.1%, 65%, and 25.6%, respectively. In addition, pruritus can significantly impair patients' quality of life ([@B6]-[@B8]). Exact pathophysiology of SM-induced itching is unknown. Drugs are used symptomatically based on individual cases ([@B9]). Chronic itch represents a burdensome clinical problem that can be resulted from various etiologies ([@B10]). The neurophysiology of pruritus is not fully understood. However, it is known that Aδ and C fibres are responsible for transmission of pruritus ([@B11]). There are numerous mediators capable of stimulating these afferent nerves resulting in itch, including biogenic amines, proteases, cytokines, and peptides ([@B10]). Inflammation is a key component in the pathogenesis of SM-induced skin complications ([@B12]). Cytokines and chemokines are inflammatory mediators and important activators of sensory nerves, thereby contributing to neurogenic inflammation, pain, and pruritus ([@B13]). Various studies revealed the role of selected matrix metalloproteinases (MMPs) in pathogenesis of several skin diseases such as dermatitis herpetiformis ([@B14]), atopic dermatitis ([@B15]), and systemic scleroderma ([@B16]). Several MMPs were previously reported to have elevated in psoriatic lesions ([@B17], [@B18]). MMPs hydrolyze most components of the extracellular matrix. The activities of MMPs are also controlled by natural tissue inhibitors of metalloproteinases (TIMPs). These proteinases play a central role in various biological processes, including normal tissue remodeling, wound healing, and angiogenesis ([@B19]).

In addition, adhesion molecules appear to play a role in the occurrence and development of pruritus, at least in certain dermatologic disorders. For example, selectins play a key role in the pathogenesis of common inflammatory skin disorders such as atopic dermatitis and psoriasis ([@B20]-[@B22]).

The role of MMPs and selectins in Skin SM induced disorders is poorly understood. To clarify the mechanisms and possible mediators involved in the pruritus in the patients exposed to SM, the present study aimed at assessing the serum levels of soluble forms of selectins (L, P, and E), MMP-9, and MMP-9/TIMPs complex in the SM exposed and matched control groups.

Materials and Methods
=====================

**Study Design and Participant**

The current study was a part of SICS and the details of methodology were previously reported ([@B23]). Brieﬂy, 368 male subjects aged 20 to 60 years exposed to SM about 20 years ago, and 126 age/gender-matched unexposed volunteers were included in the cohort. SICS was initiated in 2006 and the clinical evaluation and sample collection were done in June 2007 and the experiments were completed in six months. Clinical evaluation was performed on each volunteer participant; every volunteer was interviewed and physically examined by a dermatologist. Patients exposed to SM had multiple organ complications and were categorized into subgroups to make easier understanding of any possible relationship between serum levels of MMP-9, MMP-9/TIMPs, and selectins with skin itching. In the current study, with respect to itching, the participants were divided into four groups as follows:

1.  Patients exposed to SM with skin itching, 2) Patients exposed to SM without skin itching, 3) The control group with skin itching, and 4) The control group without skin itching.

**Ethical Considerations**

The study was approved by the Ethical Committee Board of Research Ethics of Janbazan Medical and Engineering Research Center (JMERC), and Board of Research, Iranian Ministry of Health and Medical Education, and Ethical committee of Shahed University. Potential volunteers were informed about the purpose and procedure of the study; the volunteers who signed an informed consent were recruited.

**Serum Collection**

Peripheral blood samples were drawn into vacutainer tubes (BD Biosciences). The sera were separated by centrifugation at 2000×g at 4°C for 20 minutes and stored at −80°C until laboratory measurements.

**Enzyme-linked Immunosorbent Assay Measurements**

Human MMP-9, MMP-9-TIMPs complex DuoSet® ELISA Development Kits (R&D Systems) were used to measure the components in the sera. Human sL-selectin/CD62L, sE-selectin/CD62E, and sP-selectin/CD62P Quantikine® ELISA kits (R&D Systems) were used to measure the selectin levels in the sera according to the manufacturer\'s instruction. This assay employs the quantitative sandwich enzyme immunoassay technique. The ELISA reader and washer were Stat-Fax 2100 and Stat-Fax 2600 (USA), respectively.

**Statistical Analysis**

Statistical comparison among groups was performed using Mann--Whitney test. Differences were considered statistically significant at P ≤0.05. Data were presented as mean (standard deviation) and median (first and third quartiles). Analysis of all the data was performed using SPSS software version 16.0 (Chicago, Illinois, USA).

Results
=======

In SICS study, 94.7% (n=338) of the exposed group and 63.3% (n=81) of unexposed control group had skin itching. There was a statistically significant difference between the exposed and matched control groups in terms of itching (P-value \<0.001).

**Comparison of the serum levels of MMP-9, MMP-9/TIMP-1, MMP-9/TIMP-2 and MMP-9/TIMP-4 between the patients exposed to SM with or without itching and the matched controls**

Median serum levels of MMP-9 were 624 ng/mL in the exposed group without itching and 894 ng/mL in the exposed group with itching, 855 ng/mL in the control group with itching, and 848 ng/mL in the control group without itching. The difference between the exposed groups with and without itching was statistically significant (P-value =0.034) ([Table 1](#T1){ref-type="table"}).

As shown in [tables 2](#T2){ref-type="table"}, [3](#T3){ref-type="table"}, and [4](#T4){ref-type="table"} there were no significant differences among the serum levels of MMP-9/TIMP-1, MMP-9/TIMP-2, and MMP-9/TIMP-4 between the exposed groups with without itching.

A significant increase in MMP-9/TIMP-2 complex was observed in the control group with itching compared to the control group without itching (P-value \<0.008). Also, there was a significant difference between the SM-exposed group with itching and the control group (P-value=0.019) ([Table 3](#T3){ref-type="table"}).

###### 

MMP-9 in the Control and Sulfur Mustard Exposed Groups With Itching

  MMP-9 Serum (µg/mL)                                                                           
  --------------------- --------- ------- ------- ------- -------- ------- ------- ------------ ------------
  Study groups          Itching   N       Mean    SD      Median   Q~1~    Q~3~    P-value^1^   P-value^2^
  Control               No        45      1.221   0.926   0.848    0.543   1.694   0.902        0.196
  Yes                   78        1.025   0.599   0.855   0.630    1.179           0.315        
  SM-Exposed            No        20      0.889   0.642   0.624    0.465   1.231   0.034        
  Yes                   320       1.772   2.357   0.894   0.646    1.718                        

The serum levels of MMP-9 in volunteers with and without itching were assessed and a comparison was made between the control and exposed groups, and within each groups.

P-value1: Comparison of the serum level between participants with and without itching within each group (Mann--Whitney test).

P-value2: Comparison between the exposed groups and control groups (Mann--Whitney test). Bold data shows significant differences (P-value \<0.05).

###### 

MMP-9/TIMP-1 Complex in the Control and Sulfur Mustard Exposed Groups With Itching

  MMP-9/TIMP-1 Serum (µg/mL)                                                                       
  ---------------------------- ----- -------- -------- -------- -------- -------- -------- ------- -------
  control                      No    45       35.157   43.506   18.552   9.610    51.886   0.607   0.909
  Yes                          76    27.324   28.195   18.049   7.781    32.094            0.272   
  Exposed                      No    20       32.327   34.651   16.546   1.1017   37.834   0.850   
  Yes                          317   32.263   41.168   20.646   10.032   39.898                    

P-value2: Comparison between exposed subjects and corresponding controls (Mann--Whitney test). Bold data shows significant differences at P-value \<0.05.

###### 

MMP-9/TIMP-2 Complex in the Control and Sulfur Mustard Exposed Groups With Itching

               MMP-9/TIMP-2 Serum (µg/mL)                                                            
  ------------ ---------------------------- ------- -------- ------- ------- ------- ------- ------- -------
  Control      No                           42      2.256    9.174   0.023   0.00    0.196   0.008   0.019
  Yes          78                           2.935   16.726   0.246   0.041   0.844           0.859   
  SM-Exposed   No                           20      1.343    2.919   0.439   0.00    1.194   0.272   
  Yes          316                          1.681   10.520   0.271   0.00    0.682                   

The serum levels of MMP-9/TIMP-2 complex in volunteers with and without itching were assessed and a comparison was made between the control and exposed groups, and within each group.

P-value1: Comparison between participants with and without itching within each group (Mann--Whitney test).

P-value2: Comparison between exposed subjects and corresponding controls (Mann--Whitney test). Bold data shows significant differences at P-value \<0.05

A significant increase was observed in MMP-9/TIMP-4 complex in the exposed group without itching, compared with the matched control group (P-value \<0.034) ([Table 4](#T4){ref-type="table"}).

###### 

MMP-9/TIMP-4 complex (Serum) in control and exposed groups With itching

  MMP-9/TIMP-4 Serum (ng/mL)                                                                         
  ---------------------------- ----- -------- --------- --------- -------- -------- -------- ------- -------
  Control                      No    44       58.067    133.495   18.834   15.031   26.072   0.164   0.034
  Yes                          76    89.335   229.037   21.042    15.667   40.491   \-       0.550   
  Exposed                      No    20       108.807   347.044   24.816   21.042   37.347   0.467   \-
  Yes                          315   86.626   255.396   24.502    16.302   40.79    \-       \-      

The serum levels of MMP-9/TIMP-4 complex in volunteers with and without itching were assessed and a comparison was made between the control and exposed groups, and within each group.

P-value1: Comparison of the serum level between participants with and without itching within each group (Mann--Whitney test).

P-value2: Comparison between the patients exposed to SM and the corresponding controls (Mann--Whitney test). Bold data shows the significant differences at P-value \<0.05.

###### 

sE-Selectin in the Control and Sulfur Mustard Exposed Groups With Itching

  Study Groups   Itching   SE-Selectin (pg/mL)   P-value^1^   P-value^2^   P-value^3^                                     
  -------------- --------- --------------------- ------------ ------------ ------------ -------- -------- ------- ------- -------
  Control        No        45                    23.88        11.81        28.44        22       12.435   0.150   0.909   0.004
  Yes            77        24.57                 17.01        32.82        26.587       14.925   0.124                    
  SM-Exposed     No        20                    21.695       10.2         31.83        23.94    15.869   0.084   \-      
  Yes            319       26.56                 17.33        40.09        30.483       17.685   \-                       

The serum levels of sE-Selectin in volunteers with and without itching were assessed and a comparison was made between the control and SM-exposed groups, and within each group.

P-value1: Comparison between with and without itching within each group (Mann--Whitney test).

P-value2: Comparison of the SM-exposed groups with the corresponding controls (Mann--Whitney test).

P-value3: Comparison between the SM-exposed group with itching and the control group without itching (Mann--Whitney test). Bold data shows significant differences at P-value \<0.05.

###### 

sL-Selectin in Control and Sulfur Mustard Exposed Groups With Itching

  ------------------------------------------------------------------------------------------------------------------
  Study Groups   Itching   SL-Selectin(pg/mL)   P-value^1^   P-value^2^                                     
  -------------- --------- -------------------- ------------ ------------ -------- -------- ------- ------- --------
  Control        No        45                   12.360       9.547        13.850   11.919   3.134   0.791   0.082\
                                                                                                            0.062

  Yes            77        11.820               10.140       13.750       12.203   2.98                     

  Exposed        No        20                   9.561        8.314        11.815   10.496   2.837   0.095   

  Yes            318       11.330               9.180        13.410       11.508   3.095                    
  ------------------------------------------------------------------------------------------------------------------

The serum levels of sL-Selectin in volunteers with and without itching were assessed and a comparison was made between the control and SM-exposed groups, and within each group.

P-value1: Comparison between the participants with and without itching within each group (Mann--Whitney test).

P-value2: Comparison of the SM-exposed subjects with the corresponding controls (Mann--Whitney test). Bold data shows significant differences at P-value \<0.05.

**Comparison of the Serum levels of sE-, sL-, and sP-selectins between the patients exposed to SM with or without itching and the matched controls**

Median serum levels of sE-selectin in the exposed group with itching (26.56 pg/mL) were higher than those of the SM-exposed group without itching (21.695 pg/mL). This difference was statistically insigniﬁcant (P-value=0.084). There was no significant difference between the serum levels of sE-selectin in the SM-exposed groups without itching and the matched control groups ([Table 5](#T5){ref-type="table"}).

A significant increase in sE-selectin was observed between the SM-exposed group with itching and the control group without itching (P-value \<0.004). As illustrated in [Table 6](#T6){ref-type="table"}, the serum levels of sL-selectin was lower in the SM-exposed group without itching compared with those of the SM-exposed group with itching (9.561 vs. 11.33 pg/mL, respectively).

The difference was statistically insigniﬁcant (P-value =0.095). Also, there was a difference between the subjects exposed to SM without itching and the matched controls, but this difference was statistically insigniﬁcant (P-value =0.082). As indicated in [Table 7](#T7){ref-type="table"}, the serum levels of sP-selectin were significantly lower in the SM-exposed group with and without itching, compared with their matched control groups (144.22 vs. 152.32 pg/mL, P-value =0.013 for with itching and 126.67 vs. 163.3, P-value \<0.031 for without itching groups). The difference between the SM-exposed groups with and without itching was statistically insignificant ([Table 7](#T7){ref-type="table"}).

###### 

sP-Selectin in the Control and Sulfur Mustard Exposed Groups With Itching

  -------------------------------------------------------------------------------------------------------------------------------------------------
  **Study Groups**   **Itching**   **SP-Selectin (pg/mL** **)**   **P-value** ^1^   **P-value** ^2^                                        
  ------------------ ------------- ------------------------------ ----------------- ----------------- --------- --------- -------- ------- --------
  **Control**        No            45                             163.3             128.9             204       167.632   55.18    0.779   0.031\
                                                                                                                                           0.013

  Yes                77            152.32                         126.88            217.6             173.286   60.718                     

  **Exposed**        No            20                             126.67            83.83             173.29    134.957   55.698   0.147   

  Yes                319           144.22                         116.52            178.34            152.299   50.134                     
  -------------------------------------------------------------------------------------------------------------------------------------------------

The serum levels of sP-Selectin in volunteers with and without itching were assessed and a comparison was made between the control and SM-exposed groups, and within each group.

P-value1: Comparison between the participants with and without within each group (Mann--Whitney test).

P-value2: Comparison of the subjected exposed to SM with the corresponding controls (Mann--Whitney test). Bold data shows significant differences at P-value \<0.05.

Discussion
==========

Exposure to SM leads to many delayed skin complications including itching. In SICS, the incidence of itching was reported 94.7% in the SM-exposed group, 20 years after the exposure. Exact pathophysiology of SM-induced itching is unknown.

The current study found that even after a long post-exposure period in the patients exposed to SM, an increased serum level of MMP-9 was associated with the itching. According to the obtained results, it is suggested that the SM-exposed group without itching could have overcome the SM-induced changes that cause itching through decrease in MMP-9, and in fact this effect is compensatory, whereas, in the SM-exposed subjects with itching, MMP-9 levels were not significantly different from in the ones in the control groups.

The serum levels of MMP-9/TIMP-2, and MMP-9/TIMP-4 were different between the SM-exposed individuals and the control ones, regardless of skin itching. However, the current study results did not show signiﬁcant association between the serum levels of MMP-9/TIMP-2 and MMP-9/TIMP-4 with itching in the patients exposed to SM. In the unexposed subjects with itching, the study results did not show any signiﬁcant differences in the serum levels of MMP-9, compared with those of the healthy controls, but increase in MMP-9/TIMP-2 remained significantly in association with itching.

The data suggested that MMP-9 contributed to itching in both groups; in the SM-exposed group with different expression of *MMP-9* and in the unexposed group with an imbalance between active MMP-9 and TIMP-2. Overexpression and activation of *MMPs*, or an imbalance between active MMPs and TIMPs were suggested as key factors involved in the breakdown of extracellular matrix found in a number of the disease states ([@B24]-[@B26]).

The mean level of MMP-9 in the serum of dry skin patients exposed to SM showed significant increase, compared with that of the normal individuals ([@B27]). Previous studies showed that the average amount of MMP-8 and -9, and TIMP-1 and -2 in the skin tissue sample of the mustard gas exposed victims was significantly higher than that of the normal individuals ([@B28]). Shakarjian et al., demonstrated the significant increase in the expression of *MMP-9* in mouse skin after SM exposure ([@B29]). *MMP-9* expression was also observed in inflammation cells and perilesional skin in bullous pemphigoid diseases, which pathologically resemble SM-induced skin lesion ([@B30]).

Epidermal hyper innervation observed in the dermatoses with intractable pruritus, such as atopic dermatitis, suggested that the hyper innervation was partially responsible for abnormal itch perception (31, 32). Neuronal MMPs also play a role in the penetration of nerve fibres into the extracellular matrix (33). The role of MMPs in SM-induced itching is poorly understood and further studies should be conducted to discover the meaning of the differential expression of *MMP-9* gene in the exposed patients with itching.

In addition, an increased serum concentration of E- and L-selectins was found in the subjects exposed to SM with itching. The difference between the patients exposed to SM with and without itching were at the borderline level of significance (P-values = 0.084 and 0.095, respectively, for E- and L-selectins). It was also shown that the level of E-selectin in the SM-exposed group with itching was significantly higher than that of the normal control group.

Unfortunately, there are currently limited data on the possible role of adhesion molecules in SM-induced skin disorders and pruritus, but various eye, skin, and lung diseases are also associated with the induction of soluble selectins ([@B34]-[@B36]). Atopic dermatitis (AD) is a chronic inflammatory skin disease characterized by an intensely pruritic skin rash ([@B37]). Gutge sell et al,. reported a statistically significant positive correlation between sE-selectin and disease activity in atopic dermatitis ([@B21]). Skin biopsies from inflamed skin of the patients with AD showed that upregulation of endothelial cell expression of *P- and E-selectin* ([@B38]), and the immunological changes in the patients with AD treated with cyclosporine included eosinophil count reduction and lower levels of E-selectin ([@B39]). Shimada et al., suggested that the elevated sL-selectin levels and abnormal *L-selectin* expression on some leukocyte subsets in patients with AD had correlations with AD-associated inflammation and that the serum level of sL-selectin was a serologic indicator of disease severity in AD ([@B40]). Lesional skin biopsies from patients with pruritus in psoriasis vulgaris showed overexpression of *E-selectin* on vascular endothelial cells. A significant correlation was observed between the severity of pruritus and the density of E-selectin immune reactive vessels ([@B41]). Due to their involvement in the pathogenesis of various local and systemic inflammatory disorders, selectins are now considered as potential diagnostic and therapeutic tools ([@B42]).

Conclusion
==========

The current study concluded that increased serum levels of MMP-9 and selectins 20 years after exposure to SM may have roles in pathogenesis and persistence of SM-induced itching in the exposed individuals. The mechanism of skin SM-induced itching is poorly understood. However, the similarities in altered MMP-9 and selectins levels between the patients exposed to SM with itching and other associated pathological complications could enable clinicians to understand the disease process and make better therapeutic decisions. It seems that further research is required to clarify the role of immunological parameters in the pathogenesis of SM-induced itching. However, it should be noted that exposure to SM causes alterations in the expression of various parameters of immune responses, and on the other hand, increase and decrease of SM induced immune mediators may cause disorders, whereas, some of them are considered as compensatory responses to prevent disorders. Therefore, it seems that the multifactorial mechanism of itching and achieving the desired results should be investigated further.
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